Literature DB >> 32533341

Immune microenvironment in Barrett's esophagus adjacent to esophageal adenocarcinoma: possible influence of adjacent mucosa on cancer development and progression.

Yusuke Gokon1,2, Fumiyoshi Fujishima3, Yusuke Taniyama1, Hirotaka Ishida1, Taku Yamagata4, Takashi Sawai5, Miwa Uzuki6, Hirofumi Ichikawa7, Yuko Itakura8, Kazutomi Takahashi9, Nobuhisa Yajima10, Motohisa Hagiwara11, Akiko Nishida12, Yohei Ozawa13, Tsutomu Sakuma14, Rikiya Kanba15, Kazuhiro Sakamoto16, Masashi Zuguchi17, Masahiro Saito18, Takashi Kamei1, Hironobu Sasano2.   

Abstract

The immune microenvironment plays a pivotal role in cancer development and progression. Therefore, we studied the status of immune cells in esophageal adenocarcinoma (EAC) and adjacent Barrett's esophagus (BE) and their association with the clinical course of patients. We included 87 patients with EAC who underwent surgical resection or endoscopic submucosal dissection. CD3, CD8, Foxp3, p53, and Ki-67 were immunolocalized in EAC and adjacent BE (N = 87) and BE without EAC (N = 13). BE adjacent to EAC exhibited higher CD3+ lamina propria lymphocyte (LPL) numbers than BE without EAC. Abundant Foxp3+ LPLs in BE were associated with dysplasia and increased Ki-67 labeling index (LI) in BE glandular cells and tended to link to aberrant p53 expression. Abundant CD8+ LPLs in adjacent BE were associated with worse prognosis of EAC patients (P = 0.019). Results of our present study firstly revealed the potential influence of the tissue immune microenvironment of BE adjacent to EAC on cancer development and eventual clinical outcome of EAC patients. T cell infiltration could play pivotal roles in facilitating the dysplasia-adenocarcinoma sequence in BE. The number of Foxp3+ T cells is increased at the early stage of carcinogenesis and could help identify patients harboring dysplastic and highly proliferating cells. CD8+ T cells could reflect unfavorable inflammatory response in adjacent tissue microenvironment and help predict worse prognosis of EAC patients.

Entities:  

Keywords:  Adjacent mucosa; Barrett’s esophagus; Esophageal adenocarcinoma; Immunohistochemistry; Lymphocyte; Microenvironment

Year:  2020        PMID: 32533341     DOI: 10.1007/s00428-020-02854-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  5 in total

1.  Association between mitochondrial and nuclear DNA damages and cellular senescence in the patients with biliary atresia undergoing Kasai portoenterostomy and liver transplantation.

Authors:  Yudai Nakajima; Yuto Yamazaki; Xin Gao; Masatoshi Hashimoto; Masaki Nio; Motoshi Wada; Fumiyoshi Fujishima; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2022-03-03       Impact factor: 2.309

Review 2.  Evolution and progression of Barrett's oesophagus to oesophageal cancer.

Authors:  Sarah Killcoyne; Rebecca C Fitzgerald
Journal:  Nat Rev Cancer       Date:  2021-09-20       Impact factor: 60.716

3.  Analysis of immune related gene expression profiles and immune cell components in patients with Barrett esophagus.

Authors:  Lin Shi; Renwei Guo; Zhuo Chen; Ruonan Jiao; Shuangshuang Zhang; Xuanxuan Xiong
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

4.  Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus.

Authors:  M Schoemmel; H Loeser; F Gebauer; A Quaas; M Kraemer; S Wagener-Ryczek; A Hillmer; C Bruns; M Thelen; W Schröder; T Zander; A Lechner; R Buettner; H Schlösser
Journal:  Clin Transl Oncol       Date:  2021-02-10       Impact factor: 3.405

Review 5.  Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review.

Authors:  Meng-Ying Cui; Xing Yi; Zhen-Zhen Cao; Dan-Xia Zhu; Jun Wu
Journal:  J Oncol       Date:  2022-09-05       Impact factor: 4.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.